GB Sciences, Inc. (OTCMKTS:GBLX – Get Free Report) crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $0.00 and traded as high as $0.00. GB Sciences shares last traded at $0.00, with a volume of 181,650 shares changing hands.
GB Sciences Stock Performance
GB Sciences Company Profile
GB Sciences, Inc, a phytomedical research and biopharmaceutical drug development company, engages in the research and development of plant-based medicines. The company offers cannabinoid-inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of medical conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, chronic pain, COVID-related cytokine release syndrome, depression/anxiety, and cardiovascular therapeutic programs.
Further Reading
- Five stocks we like better than GB Sciences
- Business Services Stocks Investing
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
- Investing in Commodities: What Are They? How to Invest in Them
- Top 3 ETFs to Hedge Against Inflation in 2025
- NYSE Stocks Give Investors a Variety of Quality Options
- These 3 Chip Stock Kings Are Still Buys for 2025
Receive News & Ratings for GB Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GB Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
